Literature DB >> 25344412

[First-line anti-infective treatment in sepsis].

H Burgmann1.   

Abstract

BACKGROUND: The Surviving Sepsis Campaign strongly recommends that intravenous antibiotic therapy should be started as early as possible, ideally within the first hour of recognition of severe sepsis or septic shock. There is ample evidence that failure to initiate early antimicrobial treatment correlates with increased morbidity and mortality.
OBJECTIVES: The purpose of this work was to review the recent literature regarding optimal initial antimicrobial treatment in patients with severe sepsis and sepsis shock.
MATERIALS AND METHODS: A literature review was performed.
RESULTS: The most frequently quoted papers claiming the overriding prognostic importance of early administered antibiotics are retrospective data analyses. However, an equivalent number of studies report that a group of septic patients do not benefit from early administration of antibiotics, but can also be harmed. In these patients, watchful waiting with administration of a targeted antibiotic can be used, thus, avoiding the possible collateral damage from excessive treatment with antibiotics. Treatment with monotherapy is adequate in most cases.
CONCLUSION: The administration of antibiotics based on the local epidemiology should be initiated quickly in critically ill patients with severe sepsis and septic shock. In patients who are not in septic shock, treatment can be withheld, while awaiting further studies or clinical assessment to confirm the suspicion of infection.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25344412     DOI: 10.1007/s00063-014-0378-8

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  28 in total

Review 1.  Early versus late pre-intensive care unit admission broad spectrum antibiotics for severe sepsis in adults.

Authors:  Shahla Siddiqui; Junaid Razzak
Journal:  Cochrane Database Syst Rev       Date:  2010-10-06

Review 2.  The antimicrobial therapy puzzle: could pharmacokinetic-pharmacodynamic relationships be helpful in addressing the issue of appropriate pneumonia treatment in critically ill patients?

Authors:  Federico Pea; Pierluigi Viale
Journal:  Clin Infect Dis       Date:  2006-05-10       Impact factor: 9.079

3.  Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock.

Authors:  Anand Kumar; Daniel Roberts; Kenneth E Wood; Bruce Light; Joseph E Parrillo; Satendra Sharma; Robert Suppes; Daniel Feinstein; Sergio Zanotti; Leo Taiberg; David Gurka; Aseem Kumar; Mary Cheang
Journal:  Crit Care Med       Date:  2006-06       Impact factor: 7.598

4.  [Severe infections : causes and management of sepsis].

Authors:  B Salzberger; F Hanses; G Birkenfeld; J Langgartner
Journal:  Internist (Berl)       Date:  2013-08       Impact factor: 0.743

Review 5.  [Sepsis. Update 2012].

Authors:  M Kochanek; A Shimabukuro-Vornhagen; M von Bergwelt-Baildon; G Michels
Journal:  Dtsch Med Wochenschr       Date:  2012-08-07       Impact factor: 0.628

Review 6.  [The golden hour of sepsis: initial therapy should start in the prehospital setting].

Authors:  T Chaudhary; C Hohenstein; O Bayer
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-03-05       Impact factor: 0.840

Review 7.  Does antibiotic selection impact patient outcome?

Authors:  Stephan Harbarth; Vandack Nobre; Didier Pittet
Journal:  Clin Infect Dis       Date:  2006-11-27       Impact factor: 9.079

8.  Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program.

Authors:  Ricard Ferrer; Ignacio Martin-Loeches; Gary Phillips; Tiffany M Osborn; Sean Townsend; R Phillip Dellinger; Antonio Artigas; Christa Schorr; Mitchell M Levy
Journal:  Crit Care Med       Date:  2014-08       Impact factor: 7.598

9.  Efficacy of adequate early antibiotic therapy in ventilator-associated pneumonia: influence of disease severity.

Authors:  Christophe Clec'h; Jean-François Timsit; Arnaud De Lassence; Elie Azoulay; Corinne Alberti; Maite Garrouste-Orgeas; Bruno Mourvilier; Gilles Troche; Muriel Tafflet; Olivier Tuil; Yves Cohen
Journal:  Intensive Care Med       Date:  2004-06-09       Impact factor: 17.440

Review 10.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.

Authors:  R C Bone; R A Balk; F B Cerra; R P Dellinger; A M Fein; W A Knaus; R M Schein; W J Sibbald
Journal:  Chest       Date:  1992-06       Impact factor: 9.410

View more
  2 in total

Review 1.  [Therapeutic drug monitoring and individual dosing of antibiotics during sepsis : Modern or just "trendy"?]

Authors:  A Brinkmann; A C Röhr; A Köberer; T Fuchs; J Preisenberger; W A Krüger; O R Frey
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-09-13       Impact factor: 0.840

2.  Hotspot Analysis of Sepsis Literature.

Authors:  Changhai Xu; Zhe Wang; Kaining Lu; Hongxu Jin
Journal:  Med Sci Monit       Date:  2018-08-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.